Search research articles
Contact Us
Filters
Showing results (111-120 of 272) with videos related to
Page
of 28
Sort By:
Current Oncology Reports
|
December 15, 2023
Racial Disparities in Breast Cancer: from Detection to Treatment
J C Chen, Daniel G Stover, Tarah J Ballinger, et al.
Cancer Immunology, Immunotherapy : CII
|
May 24, 2011
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy
Bethany L Mundy-Bosse, Gregory S Young, Todd Bauer, et al.
Cancer
|
November 19, 2008
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial
Barbara L Andersen, Hae-Chung Yang, William B Farrar, et al.
Advanced Biosystems
|
May 19, 2020
Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment
Vasudha C Shukla, Silvia Duarte-Sanmiguel, Ana Panic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2024
Association Between Neighborhood Opportunity, Allostatic Load, and All-Cause Mortality in Patients With Breast Cancer
J C Chen, Mohamed I Elsaid, Demond Handley, et al.
Bioinformatics and Biology Insights
|
May 5, 2017
Plasma MicroRNA Levels Following Resection of Metastatic Melanoma
Nicholas Latchana, Zachary B Abrams, J Harrison Howard, et al.
Journal of Traumatic Stress
|
March 26, 2026
Early life abuse and neglect in breast cancer survivors: Associations with physical and psychological health throughout diagnosis and survivorship
Sonal K Johal, M Rosie Shrout, Annelise A Madison, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 10, 2011
A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma
Valerie P Grignol, Thomas Olencki, Kiran Relekar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 8, 2016
A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma
Jin-Qing Liu, Fatemeh Talebian, Lisha Wu, et al.
Frontiers in Oncology
|
May 25, 2026
A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumors
Aman Chauhan, Elise C Kohn, S Percy Ivy, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 272) with videos related to
Sort By:
Page
of 28
Current Oncology Reports
|
December 15, 2023
Racial Disparities in Breast Cancer: from Detection to Treatment
J C Chen, Daniel G Stover, Tarah J Ballinger, et al.
Cancer Immunology, Immunotherapy : CII
|
May 24, 2011
Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy
Bethany L Mundy-Bosse, Gregory S Young, Todd Bauer, et al.
Cancer
|
November 19, 2008
Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial
Barbara L Andersen, Hae-Chung Yang, William B Farrar, et al.
Advanced Biosystems
|
May 19, 2020
Reciprocal Signaling between Myeloid Derived Suppressor and Tumor Cells Enhances Cellular Motility and is Mediated by Structural Cues in the Microenvironment
Vasudha C Shukla, Silvia Duarte-Sanmiguel, Ana Panic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2024
Association Between Neighborhood Opportunity, Allostatic Load, and All-Cause Mortality in Patients With Breast Cancer
J C Chen, Mohamed I Elsaid, Demond Handley, et al.
Bioinformatics and Biology Insights
|
May 5, 2017
Plasma MicroRNA Levels Following Resection of Metastatic Melanoma
Nicholas Latchana, Zachary B Abrams, J Harrison Howard, et al.
Journal of Traumatic Stress
|
March 26, 2026
Early life abuse and neglect in breast cancer survivors: Associations with physical and psychological health throughout diagnosis and survivorship
Sonal K Johal, M Rosie Shrout, Annelise A Madison, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 10, 2011
A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma
Valerie P Grignol, Thomas Olencki, Kiran Relekar, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 8, 2016
A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma
Jin-Qing Liu, Fatemeh Talebian, Lisha Wu, et al.
Frontiers in Oncology
|
May 25, 2026
A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumors
Aman Chauhan, Elise C Kohn, S Percy Ivy, et al.
Page
of 28